SCHEMBL21031205

SCHEMBL21031205

Cc1nc(-c2ccccc2)cc(-c2ccc(-c3cccc(-c4cccc(-c5ccc(-c6nc(Cc7cc(-c8ccccc8)cc(-c8nc(C)nc(-c9ccccc9)n8)c7)nc(-c7ccc(-c8ccccc8)cc7)n6)cc5)c4)c3)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KMT2A Q03164 11/20 0.44
▸ MEN1 O00255 10/20 0.44
▸ ALDH1A1 P00352 7/20 0.44
▸ MAPT P10636 7/20 0.44
▸ HPGD P15428 7/20 0.44
▸ KDM4E B2RXH2 5/20 0.43
▸ LMNA P02545 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ NTSR1 P30989 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MAOA P21397 3/20 0.37
▸ MAOB P27338 3/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20821002 0.86 L3MBTL1 (0.49) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL23660972 0.84 L3MBTL1 (0.56) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL12551684 0.84 HRH3 (0.43) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL12551666 0.83 KMT2A (0.44) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL12551681 0.83 KMT2A (0.44) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL22309290 0.81 L3MBTL1 (0.61) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL12551669 0.81 HRH3 (0.43) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL12551661 0.81 L3MBTL1 (0.44) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL21698987 0.78 MEN1 (0.65) L3MBTL1KMT2AMEN1ALDH1A1MAPT
SCHEMBL24312641 0.78 MEN1 (0.65) L3MBTL1KMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 L3MBTL1 1618/4885KMT2A 1221/4885MEN1 3802/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 L3MBTL1 1618/4885KMT2A 1221/4885MEN1 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback